Tag: biomarker-driven oncology

Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal ...

Recent studies have highlighted the complexities and challenges in treating germ cell tumors, particularly those that exhibit resistance to standard ...

In recent years, the landscape of cancer treatment has witnessed a revolutionary shift, with immunotherapy emerging as one of the ...